Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.
ATLANTA — Tirzepatide appeared highly effective in reducing weight among women with polycystic ovary syndrome (PCOS) and overweight or obesity, real-world data from a retrospective analysis of over ...
New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...
An IV infusion clinic in Cullman has been court ordered to temporarily close its doors after being accused of administering ...
Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly ...
WVTM Channel 13 on MSN
Lawsuit filed against Aurora IV and Wellness for using unapproved GLP-1s without patient consent
Several clients are suing Aurora IV and Wellness for allegedly providing unapproved substances instead of FDA-approved medications, leading to various health issues.
Positive randomized 3-month REMAIN-1 Midpoint Cohort data showed single Revitaprocedure maintained weight loss after GLP-1 ...
Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBrian Luque - Head of Investor Relations & ...
Everyday Health on MSN
Retatrutide Is a New GLP-1 Hit. But Is It Legal?
Retatrutide is a powerful experimental weight loss drug that currently lacks FDA approval. Learn how it works, plus the legal and safety risks of buying retatrutide online.
How the Dayton Dragons built a 25-year streak of sold-out success © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback